Clinical Trial Update: Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of a liposome-encapsulated mitoxantrone regimen for relapsed or refractory acute myeloid leukemia; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mitoxantrone hydrochloride liposome (Mitoxantrone hydrochloride liposome)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: AML, Relapsed Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING